Cargando…

387. Predictors of Seropositivity to SARS-CoV-2 Among Workforce Members at a Large Urban Medical Center

BACKGROUND: Prior to SARS-CoV-2 vaccination availability, medical centers workers were at significant COVID-19 (COVID) infection risk. As part of a program offering free SARS-CoV-2 serology tests to medical center employees, we examined risk factors for prior COVID infection. METHODS: From Sept. to...

Descripción completa

Detalles Bibliográficos
Autores principales: Flores, Evelyn A, Kupferwasser, Deborah, Merino, Prudencio, Tran, Donna Phan, Liu, Honghu, Huang, Yilan, Bolaris, Michael, Nguyen, Megan H, Gonzalez, Mildred, Da Silva, Wellington, Astorga-Cook, Leslie, Abueg, Angel, Mason, Holli, Miller, Loren G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644592/
http://dx.doi.org/10.1093/ofid/ofab466.588
Descripción
Sumario:BACKGROUND: Prior to SARS-CoV-2 vaccination availability, medical centers workers were at significant COVID-19 (COVID) infection risk. As part of a program offering free SARS-CoV-2 serology tests to medical center employees, we examined risk factors for prior COVID infection. METHODS: From Sept. to Dec. 2020, we advertised free IgG antibody testing to all Los Angeles County-Univ. of Southern California Medical Center (LAC+USC) workforce members (clinical and non-clinical) via repeated email blasts. Antibody was determined using the Abbott SARS-Cov-2 IgG test against SARS-CoV-2 nucleocapsid protein. Program participants were asked to fill out a detailed epidemiologic questionnaire about work and non-work COVID risks on their cell phone or on paper at the time of phlebotomy. All testing was done prior to COVID vaccine availability. RESULTS: Among approximately 10,500 workforce members, 1327 had serologies done. Among those 1273 (96%) completed the questionnaire and were included in the analysis. SARS-CoV-2 IgG antibodies were found in 60 (4.7%). In bivariate analysis, we found associations between SARS-CoV-2 seropositivity and persons who previously tested positive for COVID (OR 175.8 [95% CI 77.6 – 398.6]), persons who thought they had prior COVID but tested negative (OR 3.9 [95% CI 1.3 – 11.4]), and persons who thought they had prior COVID but did not get a COVID test (OR 4.2 [95% CI 1.4 – 12.5]). In a multivariate model of SARS-CoV-2 seropositivity examining work- and non-work-related COVID exposures (Table), seropositivity was associated with work-related COVID exposure without adequate personal protective equipment (PPE) (OR 5.1 [95% CI 2.1 – 12.2]), work-related COVID exposure with adequate PPE (OR 3.5 [95% CI 1.5 – 8.0]), never wearing a mask outside of work (OR 7.1 [95% CI 1.3 – 38.4]), and Native Hawaiian/Pacific Islander race (OR 6.6 [95% CI 1.7 – 23.4]). Seropositivity was inversely associated with living at home with multiple age groups (OR 0.4 [95% CI 0.2 – 0.8]). Multivariate Model of Exposures Associated with Positive COVID Serology Among LAC+USC Workforce Members [Image: see text] CONCLUSION: Among workers in a large urban medical center prior to COVID vaccine availability, SARS-CoV-2 seropositivity was associated with work-related COVID exposures and low mask use outside of work, suggesting that COVID transmission in workforce members occurs both via occupational and non-occupational routes. DISCLOSURES: Loren G. Miller, MD, MPH, Medline (Grant/Research Support, Other Financial or Material Support, Contributed product)Stryker (Other Financial or Material Support, Contributed product)Xttrium (Other Financial or Material Support, Contributed product)